Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share was 1.8% below analysts’ consensus estimates.
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
jumped 8.5% in the afternoon session after investors looked past a third-quarter earnings miss and focused instead on the company's decision to maintain its full-year guidance. The healthcare services company reported adjusted earnings per share of $5.27, which was 1.8% below analyst estimates and down from the prior year. Profitability also took a hit, with the operating margin contracting to 12% from 15.2% in the same period last year. On a brighter note, revenue grew 3.1% year on year to $624.9 million, meeting Wall Street's expectations. The positive stock move suggests investors were encouraged that the company reaffirmed its full-year adjusted EPS guidance of $22.15 at the midpoint, signaling confidence in its long-term outlook despite the quarterly softness.
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share was 1.8% below analysts’ consensus estimates.
Healthcare services company Chemed Corporation (NYSE:CHE)
will be announcing earnings results this Tuesday after market hours. Here’s what you need to know.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Chemed has gotten torched over the last six months - since April 2025, its stock price has dropped 23.7% to $436.07 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
jumped 1.2% in the afternoon session after the company received a stock rating upgrade from financial services firm Jefferies.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 3.1%. This performance is a noticeable divergence from the S&P 500’s 10.3% return.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share was 14.3% below analysts’ consensus estimates.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at senior health, home health & hospice stocks, starting with Chemed (NYSE:CHE).
